Listen: SVB’s long biotech shadow, pushy AI algorithms, & Icahn v. Illumina
Is AI dictating patient care? What happens when your bank falls apart? And can Illumina endure some shareholder activism? All that and more on "The Readout LOUD" this week.
News
STAT+: Guardant accuses Illumina of ‘brazen’ attempt to quash competition in ongoing legal battle
Two months after being sued by Illumina over the alleged theft of trade secrets, Bay Area biotech Guardant Health fired back this week, rejecting the DNA sequencing giant’s claims and… […]
News
STAT+: Theranos whistleblower Tyler Shultz on lessons learned, venture capital, and shutting down his own business
During the worst moments at Theranos, Tyler Shultz ran. To burn off the stress, he logged 20 miles at a clip in the mountains. And when that didn’t work, he… […]
News
STAT+: Third Rock Ventures plots next chapter after raising $1.1 billion fund
Third Rock Venture partners Abbie Celniker and Reid Huber spoke with STAT about their plans for investing their sixth and largest fund. The lion’s share of the $1.1 billion they… […]
